Evidence map›Paper›PMID 25339736›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.

Fang Wu, Marcela Catano, Ramiro Echeverry, Enrique Torre, Woldeab B Haile, Jie An, Changhua Chen, Lihong Cheng, Andrew Nicholson, Frank C Tong and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Observational
  5. Article
  6. Emerging Adulthood Is Marked by a Cortical Dendritic Arborization Phase Depending on the Actin Nucleator Cobl.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  11. Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. Brain ischemic insult induces cofilin rod formation leading to synaptic dysfunction in neurons.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  16. Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  17. Article
  18. Review
  19. Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Fang WuDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Marcela CatanoDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Ramiro EcheverryDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Enrique TorreDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Woldeab B HaileDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Jie AnDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322, Department of Pharmacology, Shandong University School of Medicine, 250100 Jinan, China.
Changhua ChenDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Lihong ChengDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Andrew NicholsonDepartment of Radiology and Imaging Sciences and.
Frank C TongDepartments of Radiology and Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322.
Jaekeun ParkWallace H. Coulter Department of Biomedical Engineering, Emory University, Atlanta, Georgia 30322, and.
Manuel YepesDepartment of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322, Department of Neurology, Veterans Affairs Medical Center, Atlanta, Georgia 30349 myepes@emory.edu.ORCID http://orcid.org/0000-0002-5224-9663
Emory University · USThe Wallace H. Coulter Department of Biomedical Engineering · US

Funding

tPA is a Neuroprotectant in the Ischemic BrainR01NS079331 · NINDS · EMORY UNIVERSITY · PI YEPES, MANUEL SALVADOR · 2013 to 2017
$1.7M
TWEAK-Induced Ischemic Neuronal DeathR01NS062073 · NINDS · EMORY UNIVERSITY · PI YEPES, MANUEL SALVADOR · 2009 to 2013
$1.7M
TWEAK-Induced Neuroinflammation and Cerebral EdemaI01BX000474 · VA · VETERANS HEALTH ADMINISTRATION · PI YEPES, MANUEL SALVADOR · 2011 to 2013
–
BLRD VA I01 BX000474NINDS NIH HHS NS-062073NINDS NIH HHS NS-079331NINDS NIH HHS R01 NS062073NINDS NIH HHS R01 NS079331
6 · The paper itself

Abstract

Spines are dendritic protrusions that receive most of the excitatory input in the brain. Early after the onset of cerebral ischemia dendritic spines in the peri-infarct cortex are replaced by areas of focal swelling, and their re-emergence from these varicosities is associated with neurological recovery after acute ischemic stroke (AIS). Urokinase-type plasminogen activator (uPA) is a serine proteinase that plays a central role in tissue remodeling via binding to the urokinase plasminogen activator receptor (uPAR). We report that cerebral cortical neurons release uPA during the recovery phase from ischemic stroke in vivo or hypoxia in vitro. Although uPA does not have an effect on ischemia- or hypoxia-induced neuronal death, genetic deficiency of uPA (uPA(-/-)) or uPAR (uPAR(-/-)) abrogates functional recovery after AIS. Treatment with recombinant uPA after ischemic stroke induces neurological recovery in wild-type and uPA(-/-) but not in uPAR(-/-) mice. Diffusion tensor imaging studies indicate that uPA(-/-) mice have increased water diffusivity and decreased anisotropy associated with impaired dendritic spine recovery and decreased length of distal neurites in the peri-infarct cortex. We found that the excitotoxic injury induces the clustering of uPAR in dendritic varicosities, and that the binding of uPA to uPAR promotes the reorganization of the actin cytoskeleton and re-emergence of dendritic filopodia from uPAR-enriched varicosities. This effect is independent of uPA's proteolytic properties and instead is mediated by Rac-regulated profilin expression and cofilin phosphorylation. Our data indicate that binding of uPA to uPAR promotes dendritic spine recovery and improves functional outcome following AIS.

Indexed as

AnimalsBrain IschemiaCells, CulturedDendritic SpinesMaleMiceMice, Inbred C57BLMice, KnockoutNervous System DiseasesProtein BindingReceptors, Urokinase Plasminogen ActivatorRecovery of FunctionStrokeTreatment OutcomeUrokinase-Type Plasminogen ActivatorReceptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen Activatorcerebral ischemiarecoverystrokeurokinase-type plasminogen activator

Identifiers

PMID25339736
PMCPMC4205548
OpenAlexW2077572522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.